HAEMONETICS CORP (HAE) research

HAEMONETICS CORP
ShareXLinkedInReddit
Sector
Health Care
Last price
$108.52
As of

HAEMONETICS CORP (HAE): 7 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-18.

As of . Source: SEC EDGAR filings for HAE. Method and limitations.

SHARE THIS CARD

Share the HAE intelligence card

A branded snapshot of HAE: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion HAE intelligence card preview
Post to X
LIVE TERMINAL

See HAE live in the terminal

Track HAE's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live HAE terminal, free

Active signals for HAE

FREE, NO ACCOUNT

Every signal on HAE, as it fires

You are seeing 5 of 37 signals recorded on HAE since 2026-05-17.

The five above landed across 2 days. The other 32 were recorded on 3 other days. 30 of the 37 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in HAE (2026Q2)

Manager / securityMarket value% portfolioQoQ
CITADEL ADVISORS LLCCUSIP 405024100 · 2026Q2$113.3M0.01%,
MILLENNIUM MANAGEMENT LLCCUSIP 405024100 · 2026Q2$42.8M0.02%,
RENAISSANCE TECHNOLOGIES LLCCUSIP 405024100 · 2026Q2$9.8M0.01%,
Point72 Asset Management, L.P.CUSIP 405024100 · 2026Q2$8.2M0.01%,
Bridgewater Associates, LPCUSIP 405024100 · 2026Q2$4.5M0.02%,
D. E. Shaw & Co., Inc.CUSIP 405024100 · 2026Q2$2.7M0.00%,
TWO SIGMA INVESTMENTS, LPCUSIP 405024100 · 2026Q2$794K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, HAE

HAE against its peers

HAE's operating margin of 11.7% ranks in the 60th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.

MetricHAEPeer medianPercentilen
Revenue FY1.3B USD1.5B USD3725
Gross margin59.0%59.9%4819
Operating margin11.7%6.0%6023
Net margin7.3%1.7%6725
Return on equity12.2%3.0%6224
P / E52.9x34.2x7714

Peers (25): WAY, MMSI, DOCS, TFX, ITGR, LIVN, RDNT, NVST, HIMS, LNTH, CHE, OPCH, IRTC, CRVL, PACS, HNGE, WGS, TMDX, AVAH, ATRC, BKD, ACHC, MASI, PRVA, GKOS. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (HAE: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more HAE signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to HAEand get the insider, 13F, options, and confluence read in one view.

Open the live HAE terminal, free